Resumen
Background: People who inject drugs (PWID)often contend with chronic pain as a result of illness and trauma, and such pain is known to have significant impacts on mental health, quality of life, and substance use behaviours. Although PWID are also known to have high rates of childhood trauma, little is known about how childhood emotional abuse may be associated with chronic pain in this population. Objective: We undertook this study to explore emotional abuse and chronic pain among PWID. Participants and setting: This study comprised a total of 1459 participants in Vancouver, Canada between June 2014 and November 2016. Methods: We employed multivariable generalized estimating equations with data derived from two prospective cohort studies of community-recruited PWID to examine the relationship between childhood emotional abuse and chronic pain in the past six months. Results: Among eligible participants, 591 (40.5%)reported childhood emotional abuse, and 760 (52.1%)reported chronic pain in the previous six months. In a multivariable analysis, experiencing childhood emotional abuse remained independently associated with chronic pain (adjusted odds ratio: 1.25; 95% confidence interval: 1.01–1.53)after adjustment for a range of socio-demographic and drug use confounders. Conclusions: Our findings suggest that childhood emotional abuse may have lasting relationships with chronic pain among PWID, potentially through established physiological and psychological mechanisms. Current chronic pain treatment may benefit from the evaluation of life course vulnerabilities that may be amenable to earlier interventions. Further, increased availability of effective trauma-informed chronic pain treatment is needed among this vulnerable population.
Idioma original | English |
---|---|
Páginas (desde-hasta) | 119-127 |
Número de páginas | 9 |
Publicación | Child Abuse and Neglect |
Volumen | 93 |
DOI | |
Estado | Published - jul. 2019 |
Publicado de forma externa | Sí |
Nota bibliográfica
Funding Information:The authors thank the study participants for their contribution to the research, as well as current and past researchers and staff. The study was supported by the US National Institutes of Health (NIH)(U01DA038886, U01DA021525). This research was undertaken, in part, thanks to funding from the Canada Research Chairs program through a Tier 1 Canada Research Chair in Inner City Medicine which supports Dr. Evan Wood, and the Canadian Institutes of Health Research (CIHR)Canadian Research Initiative on Substance Misuse (SMN–139148). Dr. Kanna Hayashi is supported by a CIHR New Investigator Award (MSH-141971), a Michael Smith Foundation for Health Research (MSFHR)Scholar Award, and the St. Paul's Foundation. Pauline Voon is supported by doctoral scholarships from the CIHR Vanier Canada Graduate Scholarship and the Pierre Elliott Trudeau Foundation. Dr. M-J Milloy is supported by a CIHR New Investigator Award, a MSFHR Scholar Award, and the US NIH (U01DA021525). His institution has received an unstructured gift from NG Biomed, Ltd. to support him. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Funding Information:
The authors thank the study participants for their contribution to the research, as well as current and past researchers and staff. The study was supported by the US National Institutes of Health (NIH) ( U01DA038886 , U01DA021525 ). This research was undertaken, in part, thanks to funding from the Canada Research Chairs program through a Tier 1 Canada Research Chair in Inner City Medicine which supports Dr. Evan Wood, and the Canadian Institutes of Health Research (CIHR) Canadian Research Initiative on Substance Misuse ( SMN–139148 ). Dr. Kanna Hayashi is supported by a CIHR New Investigator Award ( MSH-141971 ), a Michael Smith Foundation for Health Research (MSFHR) Scholar Award , and the St. Paul’s Foundation . Pauline Voon is supported by doctoral scholarships from the CIHR Vanier Canada Graduate Scholarship and the Pierre Elliott Trudeau Foundation . Dr. M-J Milloy is supported by a CIHR New Investigator Award , a MSFHR Scholar Award , and the US NIH ( U01DA021525 ). His institution has received an unstructured gift from NG Biomed, Ltd., to support him. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Publisher Copyright:
© 2019
ASJC Scopus Subject Areas
- Pediatrics, Perinatology, and Child Health
- Developmental and Educational Psychology
- Psychiatry and Mental health
PubMed: MeSH publication types
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't